Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07135583 · ClinicalTrials.gov registry record · NA

Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury

A NA study of Spinal Cord Injury Cervical and Incomplete Spinal Cord Injury, sponsored by Thomas Jefferson University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT07135583 is a NA study of Spinal Cord Injury Cervical and Incomplete Spinal Cord Injury that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 20 participants, roughly in line with the 19-participant average among 12 other Spinal Cord Injury Cervical trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07135583, a NA study of Spinal Cord Injury Cervical and Incomplete Spinal Cord Injury, is actively recruiting participants, sponsored by Thomas Jefferson University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Spinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even early death. While breathing exercises can help strengthen these muscles, they often aren't intense enough to make a big difference, especially in people with long-term injuries. This research project is exploring a new way to improve breathing in people with chronic SCI. The goal is to "wake up" the remaining nerve pathways that still connect the brain and spinal cord to the breathing muscles. By doing this, the investigators hope to make breathing exercises more effective and improve overall respiratory health. The investigators are testing a combination of two non-invasive (non-surgical) techniques: Transcutaneous Spinal Cord Stimulation (tSCS): This uses small electrical pulses delivered through the skin to stimulate the spinal cord and help activate the muscles used for breathing. Hypercapnic-Hypoxia Protocol (HiCO₂-AIH): This involves breathing air with lower oxygen and higher carbon dioxide for short periods. This naturally increases the brain's drive to breathe and may help strengthen the breathing muscles. The investigators believe that using these two techniques together will "prime" the nervous system, making it more responsive to breathing exercises. This could lead to better outcomes for people with SCI. In addition to testing this treatment, the investigators are also collecting saliva and blood samples to look for biomarkers-biological clues that might help predict who will benefit most from this therapy. These include genetic markers and signs of nerve damage in the blood. Who Can Participate The investigators are looking for adults aged 18 to 70 who: Have had a spinal cord injury for at least one year. Have an injury between the neck and upper back (from C3 to T8).

Interventions

  • OTHER Active Comparator: Single Intervention 1
  • OTHER Active Comparator: Single Intervention 2
  • BEHAVIORAL Respiratory Resistance Exercise

Study Locations (1)

Pennsylvania

  • Thomas Jefferson University Center City Campus - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-09-18
Est. Completion 2027-08-15
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT07135583

The ClinicalTrials.gov registry entry for NCT07135583 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 19-participant average among 12 other Spinal Cord Injury Cervical trials with a reported enrollment target. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Spinal Cord Injury Cervical appearing as the primary indexed condition, and to 3 interventions - of which Active Comparator: Single Intervention 1 is the first listed.

NCT07135583 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07135583 about?

NCT07135583 is a clinical study titled "Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord Injury". Spinal cord injuries (SCI) can seriously affect a person's ability to breathe. This happens because the injury can damage the nerves that control the muscles used for breathing. As a result, people with SCI often face breathing problems, a higher risk of lung infections, and even early death. While ...

What is the current status of trial NCT07135583?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-09-18. Estimated completion is 2027-08-15.

What conditions does trial NCT07135583 study?

This clinical trial studies the following conditions: Spinal Cord Injury Cervical, Incomplete Spinal Cord Injury, Spinal Cord Injury Thoracic, Spinal Cord Injury, Chronic.

What interventions are being tested in trial NCT07135583?

The interventions under investigation include: Active Comparator: Single Intervention 1 (OTHER), Active Comparator: Single Intervention 2 (OTHER), Respiratory Resistance Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT07135583?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07135583 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injury Cervical

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.